ArticleOncotarget2017
BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers.
Shuang Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it